Beginner-Friendly Investing Education for Indian & US Markets

A deep dive into Mankind Pharma's business: how a Delhi-based company cracked Tier 2/3 India, built the Manforce and Gas-O-Fast brands, and what its premium valuation means for investors.

Ambika Iyer

June 22, 2026

19 min read

Stock Deep Dive

Sun Pharma Stock Analysis: Business Model, Moat, and Investment Case

A complete Sun Pharma analysis for beginners: how the business makes money, its branded pharma moat, the Ranbaxy story, and an honest bull and bear case.

Natco Pharma: A Long-Term Investor's Honest Assessment at ₹883

A deep-dive analysis of Natco Pharma using all 12 pharma-specific metrics — revenue mix, FDA compliance, Para IV pipeline, return ratios, and valuation — at a time when the stock sits 28% off its 52-week high.

Ambika Iyer

June 19, 2026

19 min read

Investment EducationView All

Investment Education

Drug Patents, Generic Moats, and India's Global Edge in Generic Medicines

How 20-year drug patents create billion-dollar moats, why Indian generics companies broke that system, and what patent cliffs mean for investors.

AI, Protein Folding, and the Future of Drug Discovery: What Investors Should Know

How AI cracked the 50-year protein-folding problem, why it's reshaping drug discovery, and an investor's map of the companies at the frontier — with a clear-eyed view of the risks.

Biosimilars Explained: The Investment Thesis Behind Pharma's Next Big Wave

Biosimilars explained for investors: how they differ from generics, the US$300bn patent cliff, and which Indian companies stand to win.

Ambika Iyer

June 25, 2026

22 min read

New to Investing?

Master Fundamental Analysis — Step by Step

Our structured learning path takes you from zero to reading company annual reports confidently. Track your progress and unlock deeper content as you go.

Stage 1

Foundations

Stage 2

Valuation

Stage 3

Company Analysis

How to Evaluate a Pharma Stock: The Complete Investor's Guide

The 12 metrics every investor must check before buying a pharma stock, explained simply with Indian examples from Sun Pharma, Cipla, and Dr. Reddy's.

Biologics Explained: The Living-Cell Medicines Reshaping Pharma

A beginner-friendly, investor-first guide to biologics: what they are, how they're made in living cells, why they're so expensive and hard to copy, and why that matters for pharma investors.

Charlie Munger's Mental Models: A Latticework for Thinking Clearly

Charlie Munger's mental models explained: inversion, circle of competence, the Lollapalooza effect and more, each with a real story.

Ambika Iyer

June 23, 2026

19 min read